Hemab Therapeutics Holdings, Inc.
SEC CIK 2114044 · COAG · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| RA Capital Healthcare Fund LP | Director | filed 2026 - 2026 |
| RA Capital Management, LLC | Director | filed 2026 - 2026 |
| Kolchinsky Peter | Director | filed 2026 - 2026 |
| Shah Rajeev M. | Director | filed 2026 - 2026 |
| RA Capital Nexus Fund II, L.P. | Director | filed 2026 - 2026 |
| RA Capital Nexus Fund IV, L.P. | Director | filed 2026 - 2026 |
| Maraganore John | Director | filed 2026 - 2026 |
| Vaishnaw Akshay | Director | filed 2026 - 2026 |
| Bain Linda | Director | filed 2026 - 2026 |
| Sorensen Benny | Director · See Remarks | filed 2026 - 2026 |
| Tadvalkar Laura | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Madigan Catherine | Chief Medical Officer | filed 2026 - 2026 |
| Behrndt-Eriksen Mads Nikolaj | See Remarks | filed 2026 - 2026 |
| Murthy Ananthram Sreenivasa | Chief Operating Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.